| Elite Patient Care New Mexico Llc | |
|
206 S Coronado Ave Espanola NM 87532-2792 | |
| (337) 408-0797 | |
| Not Available |
| Full Name | Elite Patient Care New Mexico Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 206 S Coronado Ave, Espanola, New Mexico |
| Authorized Official Name and Position | Antonio Gamboa (OWNER) |
| Authorized Official Contact | 3374080797 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Elite Patient Care New Mexico Llc 1509 Dulles Dr Lafayette LA 70506-3718 Ph: (337) 408-0797 | Elite Patient Care New Mexico Llc 206 S Coronado Ave Espanola NM 87532-2792 Ph: (337) 408-0797 |
| NPI Number | 1598352015 |
|---|---|
| Provider Enumeration Date | 12/30/2020 |
| Last Update Date | 05/12/2023 |
| Medicare PECOS PAC ID | 9335553197 |
|---|---|
| Medicare Enrollment ID | O20210208000410 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598352015 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 363L00000X | Nurse Practitioner | (* (Not Available)) | Secondary |
| Provider Name | Nancy M Greces |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558384644 PECOS PAC ID: 2567364169 Enrollment ID: I20040123000639 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Lisa S Noya |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619938677 PECOS PAC ID: 9133172000 Enrollment ID: I20050401000966 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Diane H Cummings |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538149190 PECOS PAC ID: 6608875075 Enrollment ID: I20061212000536 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Stephanie D Flores |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1083852271 PECOS PAC ID: 8820142334 Enrollment ID: I20090818000828 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Tanya T Bryndzia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1720064835 PECOS PAC ID: 9537121603 Enrollment ID: I20120120000604 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Amy L Bubbico |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598927683 PECOS PAC ID: 4183869423 Enrollment ID: I20130314000396 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Christina Chen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1508183393 PECOS PAC ID: 7810137676 Enrollment ID: I20130628000361 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Lilia M Pedrego |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770895054 PECOS PAC ID: 9830412824 Enrollment ID: I20141223002189 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Tiffany N Johnson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1811349194 PECOS PAC ID: 1456649540 Enrollment ID: I20161005000361 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Amit Bhandari |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598929176 PECOS PAC ID: 3971773383 Enrollment ID: I20180201002254 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Naveen Kumar Gummadi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1558711606 PECOS PAC ID: 1355677386 Enrollment ID: I20190729000776 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | David Arturo Rodriguez |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780038828 PECOS PAC ID: 3971897216 Enrollment ID: I20190910002490 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Carmen Marcolina |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730720632 PECOS PAC ID: 9739513417 Enrollment ID: I20200106002121 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Kaleigh Roberts |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1962007385 PECOS PAC ID: 1557774650 Enrollment ID: I20210111000829 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Rozita Dayani |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932706223 PECOS PAC ID: 2567875339 Enrollment ID: I20210115001764 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Antonio Gamboa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1154356780 PECOS PAC ID: 2264468222 Enrollment ID: I20210208000617 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Emily Henigman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568023281 PECOS PAC ID: 8325374796 Enrollment ID: I20210208000805 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Amanda Winter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629679519 PECOS PAC ID: 2961816749 Enrollment ID: I20210208000971 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Nirja Kafle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578165486 PECOS PAC ID: 3274947056 Enrollment ID: I20210208001211 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Deanna Whitehorn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265081756 PECOS PAC ID: 6507197290 Enrollment ID: I20210218000410 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Katrina Singh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609467182 PECOS PAC ID: 7517373723 Enrollment ID: I20210315000649 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Shenif Ladak |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1376948604 PECOS PAC ID: 5890018501 Enrollment ID: I20210715002020 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Marian Stokes |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043562150 PECOS PAC ID: 9436394079 Enrollment ID: I20220315002894 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Jacqueline Hill |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336629740 PECOS PAC ID: 8426392093 Enrollment ID: I20220331001974 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Ashley Lauren Zurcher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023573359 PECOS PAC ID: 4284968363 Enrollment ID: I20220516000097 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
| Provider Name | Brian Cooper |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1366678963 PECOS PAC ID: 0547426223 Enrollment ID: I20230724003638 |
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
News Archive
Micronics, Inc., a leading developer of point of care molecular diagnostics, announced today that it has been awarded a cash grant for tax year 2009 totaling approximately $244,479 under the U.S. Government's Qualifying Therapeutic Discovery Project program.
One of the nation's biggest credit-rating firms warned New York officials and investors Monday that the state's much-improved rating is at risk as the federal government tries to claw back nearly $1.3 billion in Medicaid payments.
The International Myeloma Foundation, the oldest and largest foundation dedicated to improving the life and care of myeloma patients, today said promising data suggest a new drug called carfilzomib could become an important new option for patients whose myeloma stops responding to other therapies.
iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
› Verified 4 days ago
Whole Self Recovery Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 509 W Pueblo Dr, Espanola, NM 87532 Phone: 506-747-3368 Fax: 505-367-0077 | |
El Centro Family Health Rio Arriba Health Commons Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2010 Industrial Park Rd, Espanola, NM 87532 Phone: 505-753-7218 Fax: 505-753-5815 | |
Presbyterian Medical Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 835 Spruce St, C & D, Espanola, NM 87532 Phone: 505-747-7400 Fax: 505-747-7403 | |
Valley First Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 411 S Santa Clara Bridge Rd, Espanola, NM 87532 Phone: 505-747-6939 Fax: 505-747-6816 | |
Ch Specialty Services Nm Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 206 S Coronado Ave, Espanola, NM 87532 Phone: 337-991-9276 | |
Espanola Advanced Center For Healing Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 509 W Pueblo Dr, Espanola, NM 87532 Phone: 505-747-3368 Fax: 505-747-3368 | |
El Centro Family Health Evhs Sbhc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1111 El Llano Rd, Espanola, NM 87532 Phone: 505-753-7357 Fax: 905-747-8659 |